Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 03-2019 | 12-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,303 | 5 | 5 | N/A | N/A |
| TOTAL | $26,238 | $5 | $5 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 3,751 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 392 | 0 | 0 | 0 | 0 |
| TOTAL | $4,143 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $30,381 | $5 | $5 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,576 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 629 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 3,122 | 3 | N/A | 0 | N/A |
| Other current liabilities | 494 | N/A | N/A | N/A | N/A |
| TOTAL | $9,821 | $76 | $N/A | $35 | $35 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,293 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 129,870 | 0 | 0 | 0 | 0 |
| TOTAL | $139,163 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $148,984 | $76 | $N/A | $35 | $35 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,000 | N/A | 5,000 | N/A | N/A |
| Common Shares | 1 | 1 | N/A | 1 | N/A |
| Retained earnings | -121,908 | -71 | N/A | -35 | -35 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1 |
| TOTAL | $-118,603 | $-71 | $N/A | $-35 | $-35 |
| Total Liabilities And Equity | $30,381 | $5 | $0 | $0 | $0 |